Evidence map›Paper›PMID 16468084›Full record

Trial reportQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2006

Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).

K J Propert, M S Litwin, Y Wang, R B Alexander, E Calhoun, J C Nickel, M P O'Leary, M Pontari, M McNaughton-Collins, Chronic Prostatitis Collaborative Research Network (CPCRN)

Registry-linked trialAbstract readRandomized Controlled TrialValidation Study
PubMed Publisher
In one paragraph

Trial report in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03946163 (Iraqi Traditional Medicine for Urinary Tract Symptoms), which is not on this map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03946163 early_phase1completednot on this mapstarted 2018, after this paper: background citation

Iraqi Traditional Medicine for Urinary Tract Symptoms: The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study

TypeinterventionalSponsorAl-Kindy College of MedicineRan2018 to 2019Enrolled60ConditionsChronic Prostatitis, Chronic Pelvic Pain SyndromeArmscinnamon capsules, Placebo oral capsule
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

K J PropertDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. kpropert@cceb.upenn.edu
M S Litwin
Y Wang
R B Alexander
E Calhoun
J C Nickel
M P O'Leary
M Pontari
M McNaughton-Collins
Chronic Prostatitis Collaborative Research Network (CPCRN)

Funding

BIOSTATISTICS SUPPORT CENTER FOR CHRONIC PROSTATITISU01DK053752 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LANDIS, J RICHARD · 2000 to 2002
$3.2M
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL RESEARCH STUDU01DK053738 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LITWIN, MARK S. · 2000 to 2001
$1.2M
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL STUDIESU01DK053732 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ALEXANDER, RICHARD B · 2000 to 2001
$848k
CHRONIC PROSTATITIS CLINICAL RESEARCH CENTERU01DK053734 · NIDDK · TEMPLE UNIVERSITY · PI PONTARI, MICHEL · 2000 to 2001
$779k
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL RESEARCHU01DK053730 · NIDDK · NORTHWESTERN UNIVERSITY · PI SCHAEFFER, ANTHONY J · 2000 to 2001
$752k
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL STUDIESU01DK053736 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI O'LEARY, MICHAEL P · 2000 to 2001
$594k
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITISU01DK053746 · NIDDK · QUEEN'S UNIVERSITY AT KINGSTON · PI NICKEL, JOHN CURTIS · 2000 to 2003
$557k
NIDDK NIH HHS U01 DK53730NIDDK NIH HHS U01 DK53732NIDDK NIH HHS U01 DK53734NIDDK NIH HHS U01 DK53736NIDDK NIH HHS U01 DK53738NIDDK NIH HHS U01 DK53746NIDDK NIH HHS U01 DK53752
6 · The paper itself

Abstract

objectivesThe NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) was developed to assess symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We assessed the responsiveness of the NIH-CPSI to change over time and defined thresholds for changes perceptible to patients.

methodsWe studied 174 men with CP/CPPS who participated in a placebo-controlled randomized clinical trial. Changes from baseline to six weeks in the NIH-CPSI total score and pain, urinary, and quality of life subscores were compared to a global response assessment (GRA). Effect sizes and Guyatt statistics were calculated to evaluate responsiveness; 95% confidence intervals were produced using bootstrapping.

resultsAll scores decreased over time with the largest decrease in subjects who reported on the GRA that they were markedly improved. The NIH-CPSI total, pain, and quality of life scores were highly responsive in the improved groups; the urinary score showed minimal responsiveness. There was no evidence of responsiveness among those subjects who worsened on the trial. ROC curves identified a 6-point decline in the NIH-CPSI total score as the optimal threshold to predict treatment response.

conclusionsThe NIH-CPSI total score and pain and quality of life subscores are responsive to change over time.

Indexed as

National Institutes of Health (U.S.)Pain MeasurementSurveys and QuestionnairesAdultChronic DiseaseHumansMaleMiddle AgedProstatitisQuality of LifeUnited States

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.